SLC6A3 and Parkinson disease: Seven of these 40 relatives showed reduced 123I-beta-CIT uptake in one or more striatal subregions at baseline, and the 4 with lowest DAT binding subsequently converted to clinical PD over a 2-year follow-up period [45].